1. Home
  2. SYRE vs BFC Comparison

SYRE vs BFC Comparison

Compare SYRE & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • BFC
  • Stock Information
  • Founded
  • SYRE 2013
  • BFC 1894
  • Country
  • SYRE United States
  • BFC United States
  • Employees
  • SYRE N/A
  • BFC N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • BFC Major Banks
  • Sector
  • SYRE Health Care
  • BFC Finance
  • Exchange
  • SYRE Nasdaq
  • BFC Nasdaq
  • Market Cap
  • SYRE 1.1B
  • BFC 1.2B
  • IPO Year
  • SYRE 2016
  • BFC N/A
  • Fundamental
  • Price
  • SYRE $23.71
  • BFC $124.66
  • Analyst Decision
  • SYRE Strong Buy
  • BFC Buy
  • Analyst Count
  • SYRE 5
  • BFC 2
  • Target Price
  • SYRE $55.75
  • BFC $142.00
  • AVG Volume (30 Days)
  • SYRE 741.8K
  • BFC 66.6K
  • Earning Date
  • SYRE 11-04-2025
  • BFC 10-21-2025
  • Dividend Yield
  • SYRE N/A
  • BFC 1.44%
  • EPS Growth
  • SYRE N/A
  • BFC N/A
  • EPS
  • SYRE N/A
  • BFC 7.11
  • Revenue
  • SYRE N/A
  • BFC $168,778,000.00
  • Revenue This Year
  • SYRE N/A
  • BFC $11.79
  • Revenue Next Year
  • SYRE N/A
  • BFC $32.03
  • P/E Ratio
  • SYRE N/A
  • BFC $17.55
  • Revenue Growth
  • SYRE N/A
  • BFC N/A
  • 52 Week Low
  • SYRE $10.91
  • BFC $92.49
  • 52 Week High
  • SYRE $33.47
  • BFC $135.72
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 60.31
  • BFC 49.45
  • Support Level
  • SYRE $21.63
  • BFC $122.26
  • Resistance Level
  • SYRE $24.19
  • BFC $127.00
  • Average True Range (ATR)
  • SYRE 1.33
  • BFC 3.61
  • MACD
  • SYRE -0.26
  • BFC 0.02
  • Stochastic Oscillator
  • SYRE 67.01
  • BFC 43.23

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

Share on Social Networks: